https://www.selleckchem.com/products/BIBF1120.html
Finally, we will also briefly highlight new therapies targeting the renal microvasculature to improve renal function. To compare the efficacy and safety of CD34+ selected ex vivo T-cell depletion (TCD) vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil (PTCy-Sir-MMF) as graft-vs-host disease (GVHD) prophylaxis. We retrospectively included patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with either TCD (n=38) or PTCy-Sir-MMF (n=91). Cumulative incidence of neutrophil and plate
Like
Comment
Share
